申请人:Delalande S.A.
公开号:US04528380A1
公开(公告)日:1985-07-09
New tetrazole derivatives, characterized in that they correspond to the formula: ##STR1## in which R.sub.1 represents: either a hydrogen atom in any one of the positions 1 to 5 of the tetrazole nucleus, R designating a branched alkyl group comprising at least 5 carbon atoms or a branched alkenyl group, or a methyl group in position 2(3) of the tetrazole nucleus, R representing the (1-propyl)n butyl chain. These new derivatives are useful as medicaments, more especially for their anti-epileptic action.
新的噻唑衍生物,其特征在于它们符合以下化学式:##STR1## 其中R.sub.1代表:在噻唑核的1到5位置中的任一位置上的氢原子,R代表由至少5个碳原子组成的支链烷基或支链烯基,或者在噻唑核的2(3)位置上的甲基基团,R代表(1-丙基)n丁基链。这些新衍生物可用作药物,特别是用于其抗癫痫作用。